| 000 | 01087 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513200228.0 | ||
| 264 | 0 | _c20000119 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0167-6806 | ||
| 024 | 7 |
_a10.1023/a:1006233802863 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerez, E A | |
| 245 | 0 | 0 |
_a5-HT3 antiemetic therapy for patients with breast cancer. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cSep 1999 |
||
| 300 |
_a207-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntiemetics _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSerotonin Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 57 _gno. 2 _gp. 207-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1006233802863 _zAvailable from publisher's website |
| 999 |
_c10554119 _d10554119 |
||